{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:42:08Z","timestamp":1780393328177,"version":"3.54.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,17]],"date-time":"2017-01-17T00:00:00Z","timestamp":1484611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.ekir.2017.01.005","type":"journal-article","created":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T18:15:46Z","timestamp":1485195346000},"page":"297-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Proton Pump Inhibitors and Kidney Disease\u2014GI Upset for the Nephrologist?"],"prefix":"10.1016","volume":"2","author":[{"given":"Stephanie M.","family":"Toth-Manikowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan E.","family":"Grams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2017.01.005_bib1","first-page":"88","article-title":"Medical treatment of peptic ulcer disease","volume":"547","author":"Andersen","year":"1988","journal-title":"Acta Chir Scand Suppl"},{"key":"10.1016\/j.ekir.2017.01.005_bib2","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1007\/s10620-014-3104-8","article-title":"Gastric acid-dependent diseases: a twentieth-century revolution","volume":"59","author":"Sachs","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ekir.2017.01.005_bib3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ejim.2016.10.007","article-title":"The appropriate use of proton pump inhibitors (PPIs): need for a reappraisal","volume":"37","author":"Savarino","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ekir.2017.01.005_bib4","unstructured":"IMS Health. Top 20 Global Therapeutic Classes, 2011, Total Audited Markets. Available at: http:\/\/www.imshealth.com\/files\/web\/Corporate\/News\/Top-Line%20Market%20Data\/Top_20_Global_Therapeutic_Classes.pdf. Accessed December 14, 2016."},{"key":"10.1016\/j.ekir.2017.01.005_bib5","unstructured":"Ambulatory and Hospital Care Statistics Branch. 2012 National Ambulatory Medical Care Survey (NAMCS). Available at: https:\/\/www.cdc.gov\/nchs\/data\/ahcd\/namcs_summary\/2012_namcs_web_tables.pdf. Accessed December 14, 2016."},{"key":"10.1016\/j.ekir.2017.01.005_bib6","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3109\/0886022X.2015.1057800","article-title":"Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies","volume":"37","author":"Cheungpasitporn","year":"2015","journal-title":"Ren Fail"},{"key":"10.1016\/j.ekir.2017.01.005_bib7","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/ajg.2012.108","article-title":"Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis","volume":"107","author":"Kwok","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ekir.2017.01.005_bib8","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1503\/cmaj.092129","article-title":"Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis","volume":"183","author":"Eom","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/j.ekir.2017.01.005_bib9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00198-015-3365-x","article-title":"Proton-pump inhibitors and risk of fractures: an update meta-analysis","volume":"27","author":"Zhou","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ekir.2017.01.005_bib10","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1001\/jamaneurol.2015.4791","article-title":"Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis","volume":"73","author":"Gomm","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ekir.2017.01.005_bib11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1161\/CIRCOUTCOMES.114.001177","article-title":"Conflicting results between randomized trials and observational studies on the impact of proton pump inhibitors on cardiovascular events when coadministered with dual antiplatelet therapy: systematic review","volume":"8","author":"Melloni","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ekir.2017.01.005_bib12","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0002-9343(93)90273-R","article-title":"Omeprazole-induced acute interstitial nephritis","volume":"95","author":"Kuiper","year":"1993","journal-title":"Am J Med"},{"issue":"suppl 3","key":"10.1016\/j.ekir.2017.01.005_bib13","first-page":"61","article-title":"[Acute interstitial nephritis associated with omeprazole therapy]","volume":"24","author":"Torregrosa","year":"2004","journal-title":"Nefrologia"},{"key":"10.1016\/j.ekir.2017.01.005_bib14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5694\/j.1326-5377.2005.tb06675.x","article-title":"Acute interstitial nephritis secondary to esomeprazole","volume":"182","author":"Geevasinga","year":"2005","journal-title":"Med J Aust"},{"key":"10.1016\/j.ekir.2017.01.005_bib15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1440-1797.2005.00365.x","article-title":"Rabeprazole-induced acute interstitial nephritis","volume":"10","author":"Geevasinga","year":"2005","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.ekir.2017.01.005_bib16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0140-6736(93)92531-W","article-title":"Renal failure after omeprazole","volume":"341","author":"Christensen","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2017.01.005_bib17","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0140-6736(94)91945-3","article-title":"Recurrent acute interstitial nephritis on rechallenge with omeprazole","volume":"344","author":"Assouad","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2017.01.005_bib18","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/S0140-6736(94)91674-8","article-title":"Acute interstitial nephritis due to omeprazole","volume":"344","author":"Jones","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2017.01.005_bib19","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/j.1445-5994.1994.tb01765.x","article-title":"Omeprazole induced acute interstitial nephritis","volume":"24","author":"Lewis","year":"1994","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.ekir.2017.01.005_bib20","first-page":"280","article-title":"Acute interstitial nephritis, omeprazole and antineutrophil cytoplasmic antibodies","volume":"42","author":"Singer","year":"1994","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.ekir.2017.01.005_bib21","first-page":"129","article-title":"Acute interstitial nephritis due to omeprazole","volume":"44","author":"Fleury","year":"1995","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.ekir.2017.01.005_bib22","doi-asserted-by":"crossref","first-page":"234","DOI":"10.5694\/j.1326-5377.1996.tb124940.x","article-title":"Acute renal failure due to omeprazole","volume":"165","author":"O'Donnell","year":"1996","journal-title":"Med J Aust"},{"key":"10.1016\/j.ekir.2017.01.005_bib23","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1093\/ndt\/12.11.2414","article-title":"Acute interstitial nephritis secondary to omeprazole","volume":"12","author":"Badov","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2017.01.005_bib24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3109\/08860229709026272","article-title":"Omeprazole-induced acute interstitial nephritis","volume":"19","author":"d'Adamo","year":"1997","journal-title":"Ren Fail"},{"key":"10.1016\/j.ekir.2017.01.005_bib25","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/00004836-199709000-00011","article-title":"Omeprazole-induced interstitial nephritis","volume":"25","author":"Yip","year":"1997","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.ekir.2017.01.005_bib26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000013345","article-title":"Immunoallergic granulomatous interstitial nephritis following treatment with omeprazole","volume":"18","author":"Montseny","year":"1998","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ekir.2017.01.005_bib27","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1111\/j.1572-0241.1999.03375.x","article-title":"Omeprazole-induced acute interstitial nephritis","volume":"94","author":"Geetha","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ekir.2017.01.005_bib28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/00152193-200030100-00039","article-title":"Omeprazole and nephritis","volume":"30","author":"Shuster","year":"2000","journal-title":"Nursing"},{"key":"10.1016\/j.ekir.2017.01.005_bib29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0300-2977(00)00044-9","article-title":"Reversible renal failure after treatment with omeprazole","volume":"57","author":"Post","year":"2000","journal-title":"Neth J Med"},{"key":"10.1016\/j.ekir.2017.01.005_bib30","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/ndt\/15.9.1450","article-title":"Hypercalcaemia and acute interstitial nephritis associated with omeprazole therapy","volume":"15","author":"Wall","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2017.01.005_bib31","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1111\/j.1572-0241.2001.05345.x","article-title":"Acute interstitial nephritis due to omeprazole","volume":"96","author":"Myers","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ekir.2017.01.005_bib32","first-page":"U332","article-title":"Omeprazole-induced acute interstitial nephritis","volume":"116","author":"Delve","year":"2003","journal-title":"N\u00a0Z Med J"},{"key":"10.1016\/j.ekir.2017.01.005_bib33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1345\/aph.1D085","article-title":"Acute interstitial nephritis due to pantoprazole","volume":"38","author":"Ra","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ekir.2017.01.005_bib34","first-page":"580","article-title":"Pantoprazole-induced acute interstitial nephritis","volume":"17","author":"Moore","year":"2004","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.ekir.2017.01.005_bib35","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1136\/pgmj.74.873.416","article-title":"Pyrexia, anaemia and acute renal failure secondary to omeprazole","volume":"74","author":"Landray","year":"1998","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ekir.2017.01.005_bib36","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.cgh.2005.11.004","article-title":"Proton pump inhibitors and acute interstitial nephritis","volume":"4","author":"Geevasinga","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ekir.2017.01.005_bib37","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1440-1797.2006.00651.x","article-title":"Proton pump inhibitors and acute interstitial nephritis: report and analysis of 15 cases","volume":"11","author":"Simpson","year":"2006","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.ekir.2017.01.005_bib38","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/pds.3329","article-title":"Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute\u00a0kidney injury","volume":"21","author":"Leonard","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ekir.2017.01.005_bib39","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1471-2369-14-150","article-title":"Proton pump inhibitors and acute kidney injury: a nested case-control study","volume":"14","author":"Klepser","year":"2013","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ekir.2017.01.005_bib40","doi-asserted-by":"publisher","first-page":"E166","DOI":"10.9778\/cmajo.20140074","article-title":"Proton pump inhibitors and the risk of acute kidney injury in older patients:\u00a0a population-based cohort study","volume":"3","author":"Antoniou","year":"2015","journal-title":"CMAJ Open"},{"key":"10.1016\/j.ekir.2017.01.005_bib41","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","article-title":"Proton pump inhibitor use and the risk of chronic kidney disease","volume":"176","author":"Lazarus","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ekir.2017.01.005_bib42","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1681\/ASN.2015121377","article-title":"Proton pump inhibitors and risk of incident CKD and progression to ESRD","volume":"27","author":"Xie","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2017.01.005_bib43","doi-asserted-by":"publisher","first-page":"e3363","DOI":"10.1097\/MD.0000000000003363","article-title":"Association between the use of proton pump inhibitors and the risk of ESRD in renal diseases: a population-based, case-control study","volume":"95","author":"Peng","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ekir.2017.01.005_bib44","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/ki.2011.379","article-title":"Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis","volume":"81","author":"Coca","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2017.01.005_bib45","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-2125.2007.02927.x","article-title":"Proton pump inhibitor-induced acute interstitial nephritis","volume":"64","author":"H\u00e4rmark","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ekir.2017.01.005_bib46","doi-asserted-by":"publisher","first-page":"e112558","DOI":"10.1371\/journal.pone.0112558","article-title":"The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis","volume":"9","author":"Park","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2017.01.005_bib47","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/ki.2014.331","article-title":"Results from the Atherosclerosis Risk in Communities study suggest that low serum magnesium is associated with incident kidney disease","volume":"87","author":"Tin","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2017.01.005_bib48","first-page":"1","article-title":"Abolishment of alkaline tide by a proton pump inhibitor (PPI)\u2014an indication for successful therapy in Barrett's esophagus patients\u2014a prospective study","volume":"5","author":"Raskin","year":"2015","journal-title":"J\u00a0Gastrointest Dig Syst"},{"key":"10.1016\/j.ekir.2017.01.005_bib49","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1136\/bmj.39406.449456.BE","article-title":"Overprescribing proton pump inhibitors","volume":"336","author":"Forgacs","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.ekir.2017.01.005_bib50","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11096-006-9028-4","article-title":"Continuation of proton pump inhibitors from hospital to community","volume":"28","author":"Grant","year":"2006","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.ekir.2017.01.005_bib51","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/S0277-9536(00)00114-3","article-title":"Strategies for reducing the prescribing of proton pump inhibitors (PPIs): patient self-regulation of treatment may be an under-exploited resource","volume":"51","author":"Pollock","year":"2000","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.ekir.2017.01.005_bib52","doi-asserted-by":"publisher","first-page":"473","DOI":"10.7326\/M16-0273","article-title":"Trends in prevalence of chronic kidney disease in the United States","volume":"165","author":"Murphy","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ekir.2017.01.005_bib53","doi-asserted-by":"publisher","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","article-title":"Global prevalence of chronic kidney disease - a systematic review and meta-analysis","volume":"11","author":"Hill","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2017.01.005_bib54","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024917300050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024917300050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T00:38:53Z","timestamp":1719016733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024917300050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S2468024917300050"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2017.01.005","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proton Pump Inhibitors and Kidney Disease\u2014GI Upset for the Nephrologist?","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2017.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}